Annual report [Section 13 and 15(d), not S-K Item 405]

Acquisition (Details Narrative)

v3.25.1
Acquisition (Details Narrative) - USD ($)
May 15, 2024
Dec. 01, 2023
Mar. 01, 2023
Dec. 31, 2024
Jan. 06, 2023
Business Acquisition [Line Items]          
Payment to acquire business     $ 500,000    
C.G. Laboratories Inc. [Member]          
Business Acquisition [Line Items]          
Minority percentage     50.00%    
Moiety [Member]          
Business Acquisition [Line Items]          
Minority percentage         50.00%
Silly George Acquisition [Member]          
Business Acquisition [Line Items]          
Cash payment for acquire assets $ 400,000        
Business acquisition, number of value issued $ 200,000        
Business acquisition, number of shares issued 89,892        
Business acquisition, net profit percentage 20.00%        
Net tangible assets acquired $ 600,000        
Kenkoderm Acquisition [Member]          
Business Acquisition [Line Items]          
Cash payment for acquire assets   $ 547,000      
Payments to acquire businesses, cash earn-out   137,000      
Net tangible assets acquired   $ 169,000      
Joint Venture [Member]          
Business Acquisition [Line Items]          
Acquisition percentage     50.00%    
CG Labs [Member]          
Business Acquisition [Line Items]          
Net tangible assets acquired     $ 1,000,000    
Acquisition percentage     50.00%    
Enigma Health Joint Venture [Member]          
Business Acquisition [Line Items]          
Acquisition percentage         50.00%
Joint venture formation capital contribution       $ 20,000  
Minority interest       $ 37,000